Eli Lilly and Company(LLY)

Description: Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It operates Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new drug targets to create life-changing medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration, and chronic pain. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; and Chugai Pharmaceutical Co., Ltd, as well as development collaboration with Eli Lilly and Company for developing QIAstat-Dx IVD panel, for the detection of various APOE genotypes. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

---

Keywords: Medicine Biopharmaceutical Life Sciences Pain Diabetes Rheumatoid Arthritis Cardiovascular Disease Obesity Genomics Osteoporosis Chronic Pain Insulin Ulcerative Colitis Atopic Dermatitis Migraine Peptide Hormones Erectile Dysfunction Psoriatic Arthritis Plaque Psoriasis Fibromyalgia Benign Prostatic Hyperplasia Recombinant Proteins Spondylitis Depressive Disorder Anxiety Disorder Oncology Products Migraine Prevention Cyramza Cialis Insulin Lispro Cymbalta Alimta Basaglar Chronic Musculoskeletal Pain Episodic Cluster Headache Erbitux Forteo Humalog Humulin 70/30 Humulin N Markets Human Pharmaceuticals Non Radiographic Axial Spondylarthritis Severe Atopic Dermatitis Tyvyt

---

Home Page: www.lilly.com

Lilly Corporate Center
Indianapolis, IN 46285
United States
Phone: 317 276 2000

---

Officers

Exchange: XETRA

Country: DE : Germany

Currency: Euro (€)